Institute of Geriatrics, State Key Laboratory of Kidney Disease, Beijing Key Laboratory of Aging and Geriatrics, the Second Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Department of Radiology, Pingjin Hospital, Characteristic Medical Center of Chinese People's Armed Police Force, Tianjin, China.
Eur Radiol. 2023 Apr;33(4):2489-2499. doi: 10.1007/s00330-022-09223-2. Epub 2022 Nov 5.
This study aimed to determine the association between vessel wall enhancement and progression of arterial stenosis and clinical outcomes in patients with moyamoya (MMD) using high-resolution magnetic resonance (HRMR) vessel wall imaging.
Consecutive participants diagnosed with MMD were prospectively recruited and underwent HRMR at baseline and during follow-up, which had an interval period of ≥ 6 months and were clinically followed up for ≤ 24 months to record the occurrence of ischemic stroke. The relationship between vessel wall enhancement and arterial stenosis progression and stroke occurrence was evaluated.
HRMR vessel wall imaging was used to identify 309 stenotic lesions at the internal carotid artery (ICA) in 170 participants (mean age: 37.7 ± 11.3 years old, male: 44.1%). The baseline presence (adjusted odds ratio [aOR] = 3.57, 95% CI = 1.97-6.44, p < 0.001) and progression (aOR = 2.96, 95% CI = 1.29-6.80, p = 0.010) of vessel wall enhancement and middle cerebral artery (MCA) involvement (aOR = 4.98, 95% CI = 1.50-16.52, p = 0.009) were significantly associated with rapid progression of arterial stenosis. Furthermore, vessel wall enhancement (adjusted HR = 3.59, 95% CI = 1.33-9.70, p = 0.011) and rapid progression of arterial stenosis (adjusted HR = 4.52, 95% CI = 1.48-13.81, p = 0.008) were correlated with future stroke occurrence.
The baseline presence of vessel wall enhancement was associated with rapid progression of arterial stenosis and increased risk for stroke in MMD patients. Our findings suggest that vessel wall enhancement may serve as a predictor of disease progression and poor outcomes in MMD.
• The baseline presence of vessel wall enhancement was significantly associated with the rapid progression of arterial stenosis. • The baseline presence of vessel wall enhancement and rapid progression of arterial stenosis were both correlated with increased risk for future occurrence of stroke. • Our findings suggest that vessel wall enhancement may serve as a predictor of rapid progression of arterial stenosis and poor outcomes in MMD patients.
本研究旨在使用高分辨率磁共振(HRMR)血管壁成像来确定颅底异常血管网(MMD)患者血管壁增强与动脉狭窄进展和临床结局之间的关系。
连续招募被诊断为 MMD 的参与者,他们在基线和随访时接受 HRMR 检查,随访间隔≥6 个月,临床随访时间≤24 个月,以记录缺血性卒中的发生情况。评估血管壁增强与动脉狭窄进展和卒中发生之间的关系。
HRMR 血管壁成像在 170 名参与者的颈内动脉(ICA)中识别出 309 个狭窄病变(平均年龄:37.7±11.3 岁,男性:44.1%)。基线存在(调整后的优势比[aOR] = 3.57,95%置信区间[CI] = 1.97-6.44,p<0.001)和进展(aOR = 2.96,95%CI = 1.29-6.80,p = 0.010)以及大脑中动脉(MCA)受累(aOR = 4.98,95%CI = 1.50-16.52,p = 0.009)与动脉狭窄的快速进展显著相关。此外,血管壁增强(调整后的 HR = 3.59,95%CI = 1.33-9.70,p = 0.011)和动脉狭窄的快速进展(调整后的 HR = 4.52,95%CI = 1.48-13.81,p = 0.008)与未来卒中的发生相关。
基线时存在血管壁增强与 MMD 患者动脉狭窄的快速进展和卒中风险增加相关。我们的研究结果表明,血管壁增强可能是 MMD 患者疾病进展和不良结局的预测指标。
• 基线时存在血管壁增强与动脉狭窄的快速进展显著相关。• 基线时存在血管壁增强和动脉狭窄的快速进展均与未来卒中发生的风险增加相关。• 我们的研究结果表明,血管壁增强可能是 MMD 患者动脉狭窄快速进展和不良结局的预测指标。